Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat

Autor: Christine Rouault, René Gross, Michel Derouet, Céline Cruciani-Guglielmacci, Gérard Reach, M. Manteghetti, Mohammed Taouis, Pierre Petit, Gérard Ribes, Vincent Breil, Christophe Broca, Salwa W. Rizkalla, Bernard Pau, Alain Ktorza
Přispěvatelé: Unité de Recherches Avicoles (URA), Institut National de la Recherche Agronomique (INRA), Neurobiologie de l'Olfaction et de la Prise Alimentaire (NOPA), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Génie Biomédical et Diabète Sucré, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire de physiopathologie de la nutrition (LPN), Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Centre de pharmacologie et innovation dans le diabète (CPID), Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM), Maladies Métaboliques, Institut de Rechercjhes SERVIER, Laboratoire de Neuroendocrinologie Moléculaire de la Prise Alimentaire, Université Paris-Sud - Paris 11 (UP11)-Centre National de la Recherche Scientifique (CNRS), Centre d’études d’Agents Pathogènes et Biotechologies pour la Santé (CPBS), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), ProdInra, Migration, Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Université Montpellier 1 (UM1)
Rok vydání: 2004
Předmět:
insulinémie
MESH: Signal Transduction
Male
Sucrose
Physiology
[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology
[SDV]Life Sciences [q-bio]
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
MESH: Rats
Zucker

métabolisme nutritionnel
MESH: Rats
Sprague-Dawley

MESH: Isoleucine
rattus rattus
MESH: Glucose Clamp Technique
Rats
Sprague-Dawley

Phosphatidylinositol 3-Kinases
0302 clinical medicine
MESH: Diabetes Mellitus
Experimental

MESH: Obesity
Insulin
MESH: Animals
ComputingMilieux_MISCELLANEOUS
Euglycemic hyperinsulinemic clamp
chemistry.chemical_classification
MESH: Muscle
Skeletal

0303 health sciences
[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior
biology
[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences
Lipids
Amino acid
[SDV] Life Sciences [q-bio]
MESH: Glucose
obésité
MESH: Insulin Resistance
nutrition
Liver
Biochemistry
MESH: Hyperinsulinism
Signal transduction
diabète
Signal Transduction
Niacinamide
MESH: Enzyme Activation
medicine.medical_specialty
RAT
4-HYDROXYISOLEUCINE
MESH: Rats
030209 endocrinology & metabolism
MESH: Insulin
[INFO] Computer Science [cs]
Diabetes Mellitus
Experimental

03 medical and health sciences
Insulin resistance
MESH: Diet
Hyperinsulinism
Physiology (medical)
Internal medicine
medicine
Animals
[INFO]Computer Science [cs]
Obesity
Isoleucine
Muscle
Skeletal

résistance à l'insuline
insuline
Pancreatic hormone
030304 developmental biology
MESH: Sucrose
medicine.disease
MESH: Lipids
MESH: Male
Diet
Rats
Rats
Zucker

Enzyme Activation
Insulin receptor
Glucose
Enzyme
Endocrinology
chemistry
MESH: Phosphatidylinositol 3-Kinases
Glucose Clamp Technique
biology.protein
Insulin Resistance
MESH: Niacinamide
MESH: Liver
Zdroj: AJP-Endocrinology and Metabolism
AJP-Endocrinology and Metabolism, American Physiological Society, 2004, 287, pp.E463-E471
AJP-Endocrinology and Metabolism, American Physiological Society, 2004, 287 (3), pp.E463-E471. ⟨10.1152/ajpendo.00163.2003⟩
AJP-Endocrinology and Metabolism, 2004, 287 (3), pp.E463-E471. ⟨10.1152/ajpendo.00163.2003⟩
American Journal of Physiology. Endocrinology and Metabolism (287), E463-E471. (2004)
ISSN: 1522-1555
0193-1849
Popis: International audience; ID-1101 (4-hydroxyisoleucine), an amino acid extracted from fenugreek seeds, exhibits an interesting glucose-dependent insulin-stimulating activity. The present study was undertaken to investigate a possible extrapancreatic effect of ID-1101 on insulin signaling and action besides its previously described insulinotropic action. Insulin-sensitizing effects of ID-1101 were investigated in rat in vivo by three different approaches: 1) using euglycemic hyperinsulinemic clamps in two different rat models of insulin resistance, i.e., Zucker fa/fa rats and rats fed a sucrose-lipid diet; 2) measuring liver and muscle phosphatidylinositol (PI) 3-kinase activity after an acute injection of ID-1101 in normal and insulin-resistant diabetic rats; and 3) after chronic treatment in two rat models of insulin resistance. Euglycemic hyperinsulinemic clamp experiments revealed that ID-1101 can improve insulin resistance through an increase of peripheral glucose utilization rate in sucrose-lipid-fed rats and by decreasing hepatic glucose production in Zucker fa/fa rats. Moreover, we demonstrated that a single injection of ID-1101 activates the PI 3-kinase activity in liver and muscle from normal rats but also in muscle from diabetic rats. Finally, chronic ID-1101 treatment significantly reduced insulinemia in type 2 diabetic rats and reduced the progression of hyperinsulinemia in insulin-resistant obese Zucker fa/fa rats. These findings clearly demonstrate that ID-1101 can reduce insulin resistance through activation of the early steps of insulin signaling in peripheral tissues and in liver. In summary, ID-1101, besides its insulinotropic effect, directly improves insulin sensitivity, making it a potentially very valuable therapeutic agent for diabetes treatment.
Databáze: OpenAIRE